$43.125
0.135[0.31%]
Last update: 10:11AM Get Real Time Here
GSK reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of GSK using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/24/2024 | AM | GSK | Q1 | $0.90 | — | — | — | $8.44B | — | — | — | Get Alert |
01/31/2024 | AM | GSK | Q4 | $0.61 | $0.75 | $0.72 | -4.27% | $8.65B | $9.61B | $10.06B | 4.73% | Get Alert |
11/01/2023 | AM | GSK | Q3 | $1.11 | $1.07 | $1.27 | 18.69% | $9.24B | $9.37B | $10.27B | 9.55% | Get Alert |
07/26/2023 | AM | GSK | Q2 | $0.87 | $0.87 | $0.97 | 11.49% | $8.72B | $8.97B | $8.97B | 0.03% | Get Alert |
04/26/2023 | AM | GSK | Q1 | $32.30 | $0.82 | $0.90 | 9.76% | $7.19B | $8.06B | $8.44B | 4.75% | Get Alert |
02/01/2023 | AM | GSK | Q4 | $0.86 | $0.50 | $0.61 | 22.00% | $12.84B | $8.91B | $8.65B | -2.90% | Get Alert |
11/02/2022 | AM | GSK | Q3 | $0.37 | $0.96 | $1.11 | 15.62% | $6.63B | $8.26B | $9.24B | 11.84% | Get Alert |
07/27/2022 | AM | GSK | Q2 | $0.99 | $0.89 | $0.87 | -2.25% | $11.33B | $9.17B | $8.72B | -4.95% | Get Alert |
04/27/2022 | AM | GSK | Q1 | $0.79 | $0.95 | $1.10 | 15.79% | $10.24B | $11.70B | $13.13B | 12.19% | Get Alert |
02/09/2022 | AM | GSK | Q4 | $0.78 | $0.81 | $0.86 | 6.17% | $11.62B | $12.79B | $12.84B | 0.39% | Get Alert |
10/27/2021 | AM | GSK | Q3 | $1.15 | $1.01 | $1.26 | 24.75% | $11.24B | $11.88B | $12.44B | 4.67% | Get Alert |
07/28/2021 | AM | GSK | Q2 | $0.60 | $0.71 | $0.99 | 39.44% | $9.46B | $10.54B | $11.33B | 7.49% | Get Alert |
04/28/2021 | AM | GSK | Q1 | $1.21 | $0.76 | $0.79 | 3.95% | $11.64B | $11.06B | $10.24B | -7.44% | Get Alert |
02/03/2021 | AM | GSK | Q4 | $0.80 | $0.80 | $0.78 | -2.50% | $11.84B | $11.60B | $11.62B | 0.20% | Get Alert |
10/28/2020 | AM | GSK | Q3 | $1.19 | $1.09 | $1.15 | 5.50% | $11.54B | $11.67B | $11.24B | -3.68% | Get Alert |
07/29/2020 | AM | GSK | Q2 | $0.98 | $0.64 | $0.60 | -6.25% | $9.76B | $9.80B | $9.46B | -3.48% | Get Alert |
04/29/2020 | AM | GSK | Q1 | $0.98 | $0.89 | $1.21 | 35.96% | $9.96B | — | $11.64B | — | Get Alert |
02/05/2020 | AM | GSK | Q4 | $1.00 | $0.91 | $0.80 | -12.09% | $10.41B | $12.14B | $11.84B | -2.50% | Get Alert |
10/30/2019 | AM | GSK | Q3 | $1.15 | — | $1.19 | — | $10.28B | — | $11.54B | — | Get Alert |
GSK (GSK) is scheduled to report earnings on April 24, 2024. The last reported earnings were for reported on January 31, 2024 for Q4.
The Actual EPS was $0.72, which missed the estimate of $0.75.
The Actual Revenue was $10.1B, which beat the estimate of $9.6B.
Browse earnings estimates, EPS, and revenue on all stocks.